Verve Therapeutics, Inc. (VERV) DCF Valuation

Verve Therapeutics, Inc. (VERV) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Verve Therapeutics, Inc. (VERV) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Discover Verve Therapeutics, Inc. (VERV) true potential with our advanced DCF Calculator! Adjust crucial assumptions, explore various scenarios, and evaluate how modifications affect Verve Therapeutics, Inc. (VERV) valuation – all within one comprehensive Excel template.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 1.9 11.8 14.7 18.4 23.0 28.7 35.9
Revenue Growth, % 0 0 0 0 505.77 25 25 25 25 25
EBITDA -13.5 -39.3 -85.5 -162.9 -217.7 2.9 3.7 4.6 5.7 7.2
EBITDA, % 100 100 100 -8391.71 -1851.24 20 20 20 20 20
Depreciation .1 1.3 3.4 6.7 5.5 13.1 16.4 20.5 25.6 32.0
Depreciation, % 100 100 100 345.75 46.39 89.28 89.28 89.28 89.28 89.28
EBIT -13.6 -40.6 -88.9 -169.6 -223.1 2.9 3.7 4.6 5.7 7.2
EBIT, % 100 100 100 -8737.45 -1897.64 20 20 20 20 20
Total Cash 18.8 72.1 360.4 554.8 624.0 14.7 18.4 23.0 28.7 35.9
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 1.0 5.9
Account Receivables, % 100 100 100 52.14 50.15
Inventories .0 .0 .0 .0 .0 8.8 11.0 13.8 17.2 21.5
Inventories, % 100 100 100 0.000051519835 0 60 60 60 60 60
Accounts Payable 2.4 .0 7.1 2.4 6.6 13.4 16.8 21.0 26.2 32.8
Accounts Payable, % 100 100 100 124.88 56.44 91.29 91.29 91.29 91.29 91.29
Capital Expenditure -1.9 -3.4 -4.4 -13.2 -9.3 -5.3 -6.6 -8.2 -10.3 -12.8
Capital Expenditure, % 100 100 100 -681.71 -78.95 -35.79 -35.79 -35.79 -35.79 -35.79
Tax Rate, % -0.13764 -0.13764 -0.13764 -0.13764 -0.13764 -0.13764 -0.13764 -0.13764 -0.13764 -0.13764
EBITAT -13.4 -40.5 -87.7 -169.7 -223.4 2.9 3.7 4.6 5.7 7.1
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -12.8 -45.0 -81.6 -181.8 -227.9 2.8 11.7 14.6 18.2 22.8
WACC, % 11.4 11.41 11.4 11.41 11.41 11.4 11.4 11.4 11.4 11.4
PV UFCF
SUM PV UFCF 47.6
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 23
Terminal Value 247
Present Terminal Value 144
Enterprise Value 192
Net Debt -131
Equity Value 323
Diluted Shares Outstanding, MM 64
Equity Value Per Share 5.03

What You Will Get

  • Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to explore various scenarios.
  • Real-World Data: Verve Therapeutics, Inc. (VERV) financial data pre-loaded to accelerate your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
  • Customizable and Professional: A refined Excel model that adjusts to your valuation requirements.
  • Built for Analysts and Investors: Perfect for evaluating projections, validating strategies, and enhancing efficiency.

Key Features

  • 🔍 Real-Life VERV Financials: Pre-filled historical and projected data for Verve Therapeutics, Inc. (VERV).
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) such as WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Verve’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Verve’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • Download: Obtain the pre-prepared Excel file containing Verve Therapeutics, Inc. (VERV) financial data.
  • Customize: Modify forecasts, including revenue growth, EBITDA %, and WACC as per your analysis.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time for accurate insights.
  • Test Scenarios: Generate various projections and instantly compare the results.
  • Make Decisions: Leverage the valuation outcomes to inform your investment approach.

Why Choose This Calculator?

  • User-Friendly Interface: Tailored for both newcomers and seasoned professionals.
  • Customizable Inputs: Adjust parameters to suit your specific analysis needs.
  • Real-Time Feedback: Observe immediate updates to Verve Therapeutics’ valuation as you tweak inputs.
  • Preloaded Data: Comes with Verve Therapeutics’ actual financial figures for swift evaluations.
  • Relied Upon by Experts: Favored by investors and analysts for making well-informed choices.

Who Should Use This Product?

  • Healthcare Investors: Develop comprehensive and accurate valuation models for biotech portfolio analysis.
  • Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
  • Consultants and Advisors: Offer clients precise valuation insights for Verve Therapeutics, Inc. (VERV) stock.
  • Students and Educators: Utilize real-world data to practice and teach financial modeling in the biotech sector.
  • Biotech Enthusiasts: Gain insights into how innovative companies like Verve Therapeutics, Inc. (VERV) are valued in the market.

What the Template Contains

  • Preloaded VERV Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.